Cost-effectiveness of rotavirus vaccination in the Netherlands; the results of a consensus model

Efficacy of the pentavalent rotavirus vaccine, RotaTeq®, in Finnish infants up to 3 years of age: the Finnish Extension Study

(2010) Timo Vesikari et al.   EUROPEAN JOURNAL OF PEDIATRICS

Reduction in Acute Gastroenteritis Hospitalizations among US Children After Introduction of Rotavirus Vaccine: Analysis of Hospital Discharge Data from 18 US States

(2010) Aaron T. Curns et al.   JOURNAL OF INFECTIOUS DISEASES

European Society for Paediatric Infectious Diseases/European Society for Paediatric Gastroenterology, Hepatology, and Nutrition Evidence-Based Recommendations for Rotavirus Vaccination in Europe: Executive Summary

(2010) Timo Vesikari et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Effectiveness of the Pentavalent Rotavirus Vaccine in Preventing Gastroenteritis in the United States

(2010) F. T. Wang et al.   PEDIATRICS

Pentavalent Rotavirus Vaccine and Prevention of Gastroenteritis Hospitalizations in Australia

(2010) E. J. Field et al.   PEDIATRICS

Huge impact of assumptions on indirect effects on the cost-effectiveness of routine infant vaccination with 7-valent conjugate vaccine (Prevnar®)

(2010) Mark H. Rozenbaum et al.   VACCINE

Is it cost-effective to introduce rotavirus vaccination in the Dutch national immunization program?

(2010) Marie-Josee J. Mangen et al.   VACCINE

Estimating utility scores in young children with acute rotavirus gastroenteritis in the UK

(2010) Alan Martin et al.   JOURNAL OF MEDICAL ECONOMICS

A mathematical model of the indirect effects of rotavirus vaccination

(2009) T. VAN EFFELTERRE et al.   EPIDEMIOLOGY AND INFECTION

Rotavirus Overview

(2009) David I. Bernstein   PEDIATRIC INFECTIOUS DISEASE JOURNAL

HEALTH-RELATED QUALITY OF LIFE LOST TO ROTAVIRUS-ASSOCIATED GASTROENTERITIS IN CHILDREN AND THEIR PARENTS

(2009) Marc Brisson et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Decline and Change in Seasonality of US Rotavirus Activity After the Introduction of Rotavirus Vaccine

(2009) J. E. Tate et al.   PEDIATRICS

Impact of transmission dynamics on the cost-effectiveness of rotavirus vaccination

(2009) Eunha Shim et al.   VACCINE

The cost-effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe

(2009) Mark Jit et al.   VACCINE

RotaTeq®, a pentavalent rotavirus vaccine: Efficacy and safety among infants in Europe

(2009) Timo Vesikari et al.   VACCINE

Reduction in hospitalizations for diarrhea and rotavirus infections in New York state following introduction of rotavirus vaccine

(2009) Hwa-Gan H. Chang et al.   VACCINE

Hospitalizations associated with rotavirus gastroenteritis in Spain, 2001–2005

(2008) Ana López-de-Andrés et al.   BMC PUBLIC HEALTH

Cost–effectiveness of varicella vaccination programs: an update of the literature

(2008) Mark H Rozenbaum et al.   Expert Review of Vaccines

Cost-Effectiveness of Rotavirus Vaccination: Exploring Caregiver(s) and ``No Medical Care'' Disease Impact in Belgium

(2008) Joke Bilcke et al.   MEDICAL DECISION MAKING

Assessing the introduction of universal rotavirus vaccination in the Netherlands

(2008) T.P. Zomer et al.   VACCINE

The cost-utility of rotavirus vaccination with Rotarix™ (RIX4414) in the Netherlands

(2007) Lucas M.A. Goossens et al.   VACCINE